Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
1300 Results Found
AHA Letter to House E&C Subcommittee for May 1 Hearing on Change Healthcare Cyberattack
April 29, 2024
AHA Letter to Senate Finance Committee for May 1 Hearing on Change Healthcare Cyberattack
April 29, 2024
AHA Supports Legislation to Continue Hospital-at-home Model
The American Hospital Association comments on the discussion draft of the Hospital Inpatient Services Modernization Act to extend the acute care hospital-at-home program.
AHRMM LUC Comments to the FDA’s Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices
The AHRMM LUC members submitted comments and recommendations to the FDA's Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices. They recommend that information related to all Class I Medical Devices be included in the GUDID without exception.
AHA Comments on CMS Proposal on Accrediting Organization Oversight
AHA comments on CMS’ proposals to strengthen the agency’s oversight of accrediting organizations.
Following NYT Investigation, AHA Urges DOL to Investigate Actions of MultiPlan and Commercial Insurers
The American Hospital Association (AHA) writes regarding a recent The New York Times investigation into the disturbing incentives for data analytics firm, MultiPlan, and large commercial insurers like UnitedHealthcare, Aetna and Cigna, to cut reimbursement rates for care provided to employees of companies with self-funded employer insurance plans and increase costs for patients receiving that care.
Special Message: AHA Launches Health Equity Roadmap
Today, we’re excited to announce the launch of the Health Equity Roadmap — an innovative framework to support hospitals and health systems in their efforts to become more equitable organizations and dismantle structural barriers to health and overall well-being.
AHA Responds to Senate RFI on the SUSTAIN 340B Act Draft
AHA welcomes the opportunity to provide feedback on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of (SUSTAIN) 340B Act bipartisan discussion draft and accompanying request for information on the critically important 340B Drug Pricing Program.
AHA Letter to UnitedHealthcare RE: Molecular Pathology Reimbursement Policy
AHA addresses UnitedHealthcare’s implementation of its Molecular Pathology Reimbursement Policy on April 1, 2024.